Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

H Akan, VP Antia, M Kouba, J Sinko… - Journal of …, 2013 - academic.oup.com
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

[PDF][PDF] Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical …

H Akan, VP Antia, M Kouba, J nos Sinkó, AD Tanase… - 2013 - researchgate.net
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

H Akan, VP Antia, M Kouba, J Sinkó… - Journal of …, 2013 - search.ebscohost.com
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

H Akan, VP Antia, M Kouba, J Sinkó, AD Tănase… - 2013 - cabidigitallibrary.org
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

H Akan, VP Antia, M Kouba, J Sinkó… - The Journal of …, 2013 - europepmc.org
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

H Akan, V Antia, M Kouba, J Sinko… - JOURNAL OF …, 2013 - avesis.ankara.edu.tr
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

H Akan, VP Antia, M Kouba, J Sinko, AD Tanase… - Journal of antimicrobial …, 2013 - croris.hr
Sažetak Invasive fungal disease (IFD), predominantly aspergillosis, is associated with
significant morbidity and mortality in immunocompromised patients, especially those with …

[PDF][PDF] Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical …

H Akan, VP Antia, M Kouba, J nos Sinkó, AD Tanase… - 2013 - academia.edu
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

H Akan, VP Antia, M Kouba, J Sinkó… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

[PDF][PDF] Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical …

H Akan, VP Antia, M Kouba, J nos Sinkó, AD Tanase… - 2013 - scholar.archive.org
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …